Bisphosphonates and Bone Turnover in Premenopausal Women Receiving Adjuvant Chemotherapy

Unraveling estrogen action in osteoporosis

(2011) Susan A. Krum et al.   CELL CYCLE

Effect of risedronate on hip structural geometry: A 1-year, double-blind trial in chemotherapy-induced postmenopausal women

(2008) G.J. van Londen et al.   BONE

Reproductive Hormones and Skeletal Health in Young Women

(2008) Susan M. Ott   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer

(2008) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

(2008) Stephanie L. Hines et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

(2008) Michael Gnant et al.   LANCET ONCOLOGY